472 filings
Page 3 of 24
8-K
ncgv4x2ti5m9c438u ev
4 Mar 22
Departure of Directors or Certain Officers
4:45pm
8-K
fj3kn4
24 Feb 22
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum
4:11pm
8-K
y1kfwt3
15 Feb 22
OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance
4:45pm
8-K
btf0q3yubkjrmf0
22 Dec 21
OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes
4:45pm
8-K
a5ltko150kqc3m
15 Nov 21
Results of Operations and Financial Condition
4:45pm
8-K
c3twza5kku5yr
10 Nov 21
OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased
8:00am
8-K
v2cuvbv7qz65
19 Oct 21
Departure of Directors or Certain Officers
4:45pm
8-K
43ihw lyagrhxh2c29
30 Sep 21
OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer
4:45pm
8-K
fqrubrq
29 Sep 21
Other Events
4:30pm
8-K
mxz9vwl9enyb fheh
14 Sep 21
OptimizeRx Announces Significant Platform Enhancement to Digitize Pharmaceutical Access Solutions
4:15pm
8-K
pgkyd5p hlenqxu
8 Sep 21
Other Events
4:15pm
8-K
bcs3 osyg
7 Sep 21
OptimizeRx Recognized as a Finalist in Questex’s Fierce Pharma Marketing Awards 2021
4:15pm
8-K
x35n1bu2
1 Sep 21
OptimizeRx to Present at Upcoming September Investor Conferences
4:30pm
S-8
msn2u3ad
31 Aug 21
Registration of securities for employees
5:18pm
S-8 POS
ic5k2 ctup534r6slf2
31 Aug 21
Registration of securities for employees (post-effective amendment)
4:00pm
8-K
tekfarz8xxyuwo
31 Aug 21
Other Events
3:59pm
8-K
7ban695
25 Aug 21
Departure of Directors or Certain Officers
4:45pm
8-K
3z5 zagy95
17 Aug 21
The Companies’ combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction
4:15pm